165 related articles for article (PubMed ID: 11993225)
1. [Chemotherapy for the patients with esophageal cancer].
Ando N; Shih CH
Nihon Geka Gakkai Zasshi; 2002 Apr; 103(4):359-63. PubMed ID: 11993225
[TBL] [Abstract][Full Text] [Related]
2. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
[TBL] [Abstract][Full Text] [Related]
3. Surgical resection with and without chemotherapy in oesophageal cancer.
Chander S
Lancet; 2002 Oct; 360(9340):1174; author reply 1175. PubMed ID: 12387979
[No Abstract] [Full Text] [Related]
4. Surgical resection with and without chemotherapy in oesophageal cancer.
Bosset JF; Mercier M; Triboulet JP; Conroy T; Seitz JF
Lancet; 2002 Oct; 360(9340):1173-4; author reply 1175. PubMed ID: 12387978
[No Abstract] [Full Text] [Related]
5. Preoperative combined modality therapy with paclitaxel, carboplatin, prolonged infusion 5-fluorouracil, and radiation therapy in localized esophageal cancer: preliminary results of a Minnie Pearl Cancer Research Network phase II trial.
Meluch AA; Hainsworth JD; Gray JR; Thomas M; Whitworth PL; Davis JL; Greco FA
Cancer J Sci Am; 1999; 5(2):84-91. PubMed ID: 10198730
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of preoperative paclitaxel/cisplatin with radiotherapy in locally advanced esophageal cancer.
Kim DW; Blanke CD; Wu H; Shyr Y; Berlin J; Beauchamp RD; Chakravarthy B
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):397-404. PubMed ID: 17097833
[TBL] [Abstract][Full Text] [Related]
7. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.
Choi N; Park SD; Lynch T; Wright C; Ancukiewicz M; Wain J; Donahue D; Mathisen D
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):111-22. PubMed ID: 15337546
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of cisplatin, 5-fluorouracil, and paclitaxel regimen for carcinoma of the esophagus.
Belani CP; Luketich JD; Landreaneau RJ; Kim R; Ramanathan RK; Day R; Ferson PF; Keenan RJ; Posner M; Seeger J; Lembersky B
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-89-S19-92. PubMed ID: 9427275
[TBL] [Abstract][Full Text] [Related]
9. [Neoadjuvant treatment of operable esophageal cancers].
Azria D; Ychou M; Senesse P; Dubois JB
Gastroenterol Clin Biol; 1999 Oct; 23(10):1107-8. PubMed ID: 10592891
[No Abstract] [Full Text] [Related]
10. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer.
Kelsen DP; Ginsberg R; Pajak TF; Sheahan DG; Gunderson L; Mortimer J; Estes N; Haller DG; Ajani J; Kocha W; Minsky BD; Roth JA
N Engl J Med; 1998 Dec; 339(27):1979-84. PubMed ID: 9869669
[TBL] [Abstract][Full Text] [Related]
11. Prospective non-randomized study of preoperative concurrent platinum plus 5-fluorouracil-based chemoradiotherapy with or without paclitaxel in esophageal cancer patients: long-term follow-up.
Zemanova M; Petruzelka L; Pazdro A; Kralova D; Smejkal M; Pazdrova G; Honova H
Dis Esophagus; 2010 Feb; 23(2):160-7. PubMed ID: 19515190
[TBL] [Abstract][Full Text] [Related]
12. Surgical resection with and without chemotherapy in oesophageal cancer.
Maraveyas A; O'Boyle C; Cowen M
Lancet; 2002 Oct; 360(9340):1174-5; author reply 1175. PubMed ID: 12387981
[No Abstract] [Full Text] [Related]
13. Surgical resection with and without chemotherapy in oesophageal cancer.
Rath GK; Sharma DN; Shukla NK
Lancet; 2002 Oct; 360(9340):1174; author reply 1175. PubMed ID: 12387980
[No Abstract] [Full Text] [Related]
14. Preoperative induction of CPT-11 and cisplatin chemotherapy followed by chemoradiotherapy in patients with locoregional carcinoma of the esophagus or gastroesophageal junction.
Ajani JA; Walsh G; Komaki R; Morris J; Swisher SG; Putnam JB; Lynch PM; Wu TT; Smythe R; Vaporciyan A; Faust J; Cohen DS; Nivers R; Roth JA
Cancer; 2004 Jun; 100(11):2347-54. PubMed ID: 15160337
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant chemotherapy for gastro-oesophageal cancer with epirubicin, cisplatin and fluorouracil: a single-centre experience.
Strickland AH; Karapetis CS; Yip D; Harper PG
Clin Oncol (R Coll Radiol); 2001; 13(1):66. PubMed ID: 11292143
[No Abstract] [Full Text] [Related]
16. [Chemotherapy for esophageal cancer].
Nabeya Y; Ochiai T
Gan To Kagaku Ryoho; 2003 Nov; 30(12):1873-80. PubMed ID: 14650953
[TBL] [Abstract][Full Text] [Related]
17. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907).
Ando N; Kato H; Igaki H; Shinoda M; Ozawa S; Shimizu H; Nakamura T; Yabusaki H; Aoyama N; Kurita A; Ikeda K; Kanda T; Tsujinaka T; Nakamura K; Fukuda H
Ann Surg Oncol; 2012 Jan; 19(1):68-74. PubMed ID: 21879261
[TBL] [Abstract][Full Text] [Related]
18. Concurrent cisplatin, 5-FU, paclitaxel, and radiation therapy in patients with locally advanced esophageal cancer.
Roof KS; Coen J; Lynch TJ; Wright C; Fidias P; Willett CG; Choi NC
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1120-8. PubMed ID: 16730135
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of weekly irinotecan/cisplatin in advanced esophageal cancer.
Ilson DH
Oncology (Williston Park); 2004 Dec; 18(14 Suppl 14):22-5. PubMed ID: 15685830
[TBL] [Abstract][Full Text] [Related]
20. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone.
Ancona E; Ruol A; Santi S; Merigliano S; Sileni VC; Koussis H; Zaninotto G; Bonavina L; Peracchia A
Cancer; 2001 Jun; 91(11):2165-74. PubMed ID: 11391598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
